Expanded Access for Apixaban
Latest Information Update: 22 Jul 2022
At a glance
- Drugs Apixaban (Primary)
- Indications Thromboembolism
- Focus Expanded access; Therapeutic Use
- Sponsors Bristol-Myers Squibb
Most Recent Events
- 17 Jan 2022 New trial record